Enhanced Recovery After Surgery (ERAS) consensus recommendations for opioid-minimising pharmacological neonatal pain

Mercedes Pilkington1,2, Brandon Pentz3, Kristin Short4

  • 1Department of Surgery, Division of Pediatric General and Thoracic Surgery, University of Toronto Temerty Faculty of Medicine, Toronto, Canada mpilkington@ariadnelabs.org.

BMJ Paediatrics Open
|October 9, 2024
PubMed

Insights

Evidence-based guidelines recommend using regular acetaminophen and considering locoregional analgesia for neonatal pain management. These strategies aim to minimize opioid use in neonates undergoing surgery, ensuring better pain control with fewer side effects.

Area of Science:

  • Pediatric Anesthesiology
  • Neonatal Surgery
  • Pain Management

Background:

  • Enhanced Recovery After Surgery (ERAS) guidelines are established for pediatric and neonatal care.
  • A critical need exists for evidence-based recommendations on managing neonatal perioperative pain.
  • Optimizing analgesia while minimizing adverse effects is paramount in neonatal surgical care.

Purpose of the Study:

  • To develop consensus recommendations for managing neonatal pain perioperatively.
  • To establish evidence-based strategies for opioid-sparing pain management in neonates.
  • To guide the pharmacologic management of pain in neonates undergoing surgery.

Main Methods:

  • A modified Delphi consensus process was employed by an international guideline development committee.
  • Systematic literature review and critical appraisal of studies on non-opioid and locoregional analgesia.
  • Recommendations were assessed using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) framework.

Main Results:

  • The study population included neonates over 32 weeks gestational age within 30 days of life.
  • Two key recommendations emerged: regular use of acetaminophen and consideration of locoregional analgesia.
  • Moderate quality evidence supports these recommendations; insufficient evidence exists for other non-opioid adjuncts.

Conclusions:

  • Evidence-based, ERAS-driven recommendations were developed to reduce opioid exposure in neonates.
  • Further research is necessary to refine multimodal pain management strategies for this population.
  • The guidelines aim to improve pain control and minimize side effects in neonatal surgical patients.
Abstract

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
540
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
237
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
188
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
417
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
106
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
555